C

Caris Life Sciences Inc
NASDAQ:CAI

Watchlist Manager
Caris Life Sciences Inc
NASDAQ:CAI
Watchlist
Price: 28 USD -1.62% Market Closed
Market Cap: 7.9B USD

Wall Street
Price Targets

CAI Price Targets Summary
Caris Life Sciences Inc

Wall Street analysts forecast CAI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAI is 38.42 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.

Lowest
Price Target
28.28 USD
1% Upside
Average
Price Target
38.42 USD
37% Upside
Highest
Price Target
47.25 USD
69% Upside
Caris Life Sciences Inc Competitors:
Price Targets
MSB
Mesoblast Ltd
22% Upside
086900
Medy Tox Inc
15% Upside
BIOCON
Biocon Ltd
12% Upside
PYXS
Pyxis Oncology Inc
509% Upside
CRBU
Caribou Biosciences Inc
560% Upside
600201
Jinyu Bio-Technology Co Ltd
40% Downside
300676
BGI Genomics Co Ltd
28% Upside
2696
Shanghai Henlius Biotech Inc
69% Upside

Revenue
Forecast

Revenue Estimate
Caris Life Sciences Inc

The compound annual growth rate of Caris Life Sciences Inc's revenue for the next 4 years is 36%.

N/A
Past Growth
36%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Caris Life Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Caris Life Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAI's stock price target?
Price Target
38.42 USD

According to Wall Street analysts, the average 1-year price target for CAI is 38.42 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.

What is Caris Life Sciences Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Caris Life Sciences Inc's revenue for the next 4 years is 36%.

Back to Top